Literature DB >> 2037410

Intralesional alpha 2b recombinant interferon for basal cell carcinomas.

V Boneschi1, L Brambilla, G Chiappino, N Mozzanica, A F Finzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2037410     DOI： 10.1111/j.1365-4362.1991.tb03859.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  2 in total

1.  Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon alpha-2a : Evaluation of Long-Term Follow-Up Results.

Authors:  Seher Bostanci; Pelin Kocyigit; Ayşegül Alp; Cengizhan Erdem; Erbak Gürgey
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

2.  Local interferon therapy for lip carcinoma.

Authors:  D Ikić; I Padovan; N Pipić; N Daković; Z Kusić
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.